Pneumonia News

Occupational hazards, which include inhaling vapors, gas, dust or fumes at work, may be responsible for a number of noncancerous lung diseases, according to a joint American Thoracic Society and European Respiratory Society statement.

Bacteremia is uncommon among children hospitalized with community-acquired pneumonia, or CAP, according to a study published in Pediatrics. However, bacteremic children with CAP tended to have more severe disease.

A novel automated cough-sound analyzer technology incorporated in a smartphone app shows potential as a high-level diagnostic aid in the assessment of common pediatric respiratory diseases, according to results from a prospective, multicenter study published in Respiratory Research.

The FDA has approved a new indication for Zerbaxa for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia in patients aged 18 years and older.

Healio Pulmonology has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology in May.

Children presenting to EDs and other outpatient settings with community-acquired pneumonia, or CAP, often receive unnecessary diagnostic interventions and treatments, including chest X-rays and antibiotic therapy, according to research published in the Journal of the Pediatric Infectious Disease Society.

Young children with bacterial pneumonia who were admitted to a pediatric ICU frequently had lung problems that lasted up to a year after discharge, according to research presented at the American Thoracic Society International Conference.

When compared with health care-associated pneumonia criteria, electronic calculation of a prediction score more accurately predicted the risk for drug-resistant pathogens in patients with community-acquired pneumonia, new data published in Chest suggest.

DESTIN, Fla. — Interstitial pneumonia with autoimmune features may potentially be the newest category of undifferentiated connective tissue disease, according to Judith James, MD, PhD, of the Oklahoma Medical Research Foundation and the Oklahoma University Health Science Center.

New data suggest that treating community-acquired pneumonia with corticosteroids in addition to antibiotics may lead to significant cost-savings to the health care system, particularly among those with severe disease.